At one institution, the guidelines are not as effective as many had hoped, according to new post-implementation data.

Munir Ghesani, MD, President of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), system chief of nuclear medicine at Mount Sinai Health, explains recent advances in nuclear imaging technology.

After experts from one institution evaluated 500 portable chest x-rays completed during the summer of 2021, it was revealed that 46.2% of the images obtained were problematic, requiring the imaging to be repeated. 

The biggest news from the American Society of Nuclear Cardiology (ASNC) 2022 meeting was positive late-breaking data on the phase 3 Aurora trial for the flurpiridaz (F-18) PET radiotracer agent.

A new analysis offers a detailed comparison of soft-tissue lymphomas and soft-tissue tumors based on imaging characteristics from MRI scans—an area of study that has not yet been rigorously explored, the authors of the paper indicated.

When combined with artificial intelligence-based noise reduction techniques, new photon-counting CT technology can increase the detection of bone disease while also decreasing radiation exposure. 

Authors of the new EJR paper explained that, although most of these tumors present in a similar way—with a lump or localized pain—their origins are wide-ranging and require the use of additional imaging to characterize the lesion. 

Society of Breast Imaging (SBI) President John Lewin, MD, explains breast tomosynthesis has already become the default standard in mammography today.